VISTAGEN THERAPEUTICS, INC. Debt Conversion, Original Debt, Amount
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Debt Conversion, Original Debt, Amount of $4.50 million for the 3-month period ending 2015-06-23, per its 10-K filed 2015-06-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2015-06-29
- VISTAGEN THERAPEUTICS, INC. debt conversion, original debt, amount for the quarter ending 2015-06-23 was $4.50M.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 184 month |
|---|---|---|
| 2015-06-23 | $4.50M 10-K · filed 2015-06-29 | |
| 2014-03-31 | $893.70K 10-K · filed 2014-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |